170 related articles for article (PubMed ID: 14734487)
1. Proceedings of the Third International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: conference summary statement.
Come SE; Buzdar AU; Arteaga CL; Bissell MJ; Brown MA; Ellis MJ; Goss PE; Green JE; Ingle JN; Lee AV; Medina D; Nicholson RI; Santen RJ; Schiff R; Hart CS
Clin Cancer Res; 2004 Jan; 10(1 Pt 2):327S-330S. PubMed ID: 14734487
[No Abstract] [Full Text] [Related]
2. Proceedings of the 3rd International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer.
Clin Cancer Res; 2004 Jan; 10(1 Pt 2):327S-409S; quiz i-iv. PubMed ID: 14981797
[No Abstract] [Full Text] [Related]
3. Proceedings of the Fifth International Conference on Recent Advances and Future Directions in Endocrine Therapy for Breast Cancer: conference summary statement.
Come SE; Buzdar AU; Ingle JN; Arteaga CL; Brown M; Dowsett M; Hilsenbeck SG; Kumar R; Johnston SR; Lee AV; Paik S; Pritchard KI; Winer EP; Hart C
Clin Cancer Res; 2006 Feb; 12(3 Pt 2):997s-1000s. PubMed ID: 16467115
[No Abstract] [Full Text] [Related]
4. Proceedings of the Fourth International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: conference summary statement.
Come SE; Buzdar AU; Ingle JN; Arteaga CL; Brodie AM; Colditz GA; Johnston SR; Kristensen VN; Lønning PE; McDonnell DP; Osborne CK; Russo J; Santen RJ; Yee D; Hart CS
Clin Cancer Res; 2005 Jan; 11(2 Pt 2):861s-4s. PubMed ID: 15701878
[No Abstract] [Full Text] [Related]
5. Proceedings of the 2nd International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer. Cambridge, Massachusetts, USA, June 28-29, 2002.
Clin Cancer Res; 2003 Jan; 9(1 Pt 2):443S-532S; quiz i-vi. PubMed ID: 12838958
[No Abstract] [Full Text] [Related]
6. Second International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: summary consensus statement.
Come SE; Buzdar AU; Arteaga CL; Brodie AM; Davidson NE; Dowsett M; Ingle JN; Johnston SR; Lee AV; Osborne CK; Pritchard KI; Vogel VG; Winer EP; Hart CS
Clin Cancer Res; 2003 Jan; 9(1 Pt 2):443S-6S. PubMed ID: 12538498
[No Abstract] [Full Text] [Related]
7. Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer. Proceedings of the 5th International Conference, Cambridge, Massachusetts, USA, June 13-14, 2005.
Clin Cancer Res; 2006 Feb; 12(3 Pt 2):997s-1068s. PubMed ID: 16541524
[No Abstract] [Full Text] [Related]
8. Proceedings of the First International Conference on Recent Advances and Future Directions in Endocrine Therapy for Breast Cancer: summary consensus statement.
Buzdar AU; Come SE; Brodie A; Ellis M; Goss PE; Ingle JN; Johnston SR; Lee AV; Osborne CK; Vogel VG; Hart CS
Clin Cancer Res; 2001 Dec; 7(12 Suppl):4335s-4337s; discussion 4411s-4412s. PubMed ID: 11916221
[No Abstract] [Full Text] [Related]
9. Recent advances and future directions in endocrine manipulation of breast cancer. Proceedings of the Fourth International Conference. July 21-22, 2004. Cambridge, Massachusetts, USA.
Clin Cancer Res; 2005 Jan; 11(2 Pt 2):861s-960s. PubMed ID: 15875333
[No Abstract] [Full Text] [Related]
10. Current status of endocrine therapy for metastatic breast cancer.
Kimmick G; Muss HB
Oncology (Williston Park); 1995 Sep; 9(9):877-86, 889-90; discussion 892-4. PubMed ID: 8562327
[TBL] [Abstract][Full Text] [Related]
11. Hormonal modulation in the treatment of breast cancer.
Adelson K; Germain D; Raptis G; Biran N
Endocrinol Metab Clin North Am; 2011 Sep; 40(3):519-32, viii. PubMed ID: 21889718
[TBL] [Abstract][Full Text] [Related]
12. NCCN Guideline update: Breast Cancer Version 1.2004.
National Comprehensive Cancer Network
J Natl Compr Canc Netw; 2004 May; 2(3):183-4. PubMed ID: 19795602
[No Abstract] [Full Text] [Related]
13. [Hormonal and genotoxic aspects of BRCA1-associated carcinogenesis].
Bershteĭn LM
Vopr Onkol; 2007; 53(6):642-53. PubMed ID: 18416131
[No Abstract] [Full Text] [Related]
14. Current controversies in breast cancer management.
Morrow M; Jordan VC; Takei H; Gradishar WJ; Pierce LJ
Curr Probl Surg; 1999 Mar; 36(3):163-216. PubMed ID: 10089889
[No Abstract] [Full Text] [Related]
15. Endocrine and targeted manipulation of breast cancer: summary statement for the Sixth Cambridge Conference.
Come SE; Buzdar AU; Ingle JN; Johnston SRD; Brodie AM; Coombes RC; Miller WR; Pritchard KI; Winer EP; Zujewski JA; Goss PE
Cancer; 2008 Feb; 112(3 Suppl):673-678. PubMed ID: 18072254
[TBL] [Abstract][Full Text] [Related]
16. Endocrine therapy of breast cancer. A background.
Nordenskjöld B
Acta Oncol; 1990; 29(3):367-9. PubMed ID: 2194538
[No Abstract] [Full Text] [Related]
17. [Endocrine therapy for postmenopausal breast cancer (role of cycline D1)].
Manikhas AG; Skvortsov VA; Manikhas GM; Raskin GA; Oganesian AS; Shemerovskiĭ AK
Vopr Onkol; 2011; 57(5):641-4. PubMed ID: 22238936
[No Abstract] [Full Text] [Related]
18. Playing the old piano: another tune for endocrine therapy?
Hayes DF
J Natl Cancer Inst; 2003 Nov; 95(21):1565-7. PubMed ID: 14600082
[No Abstract] [Full Text] [Related]
19. Changing concepts of hormone receptor-positive advanced breast cancer therapy.
Chlebowski RT
Clin Breast Cancer; 2013 Jun; 13(3):159-66. PubMed ID: 23228361
[No Abstract] [Full Text] [Related]
20. Proceedings of the 5th International Conference on Neoadjuvant Hormonal Therapy for Prostate Cancer. Cambridge, Massachusetts, March 17-18, 2000.
Mol Urol; 2000; 4(3):89-293; quiz 297-302. PubMed ID: 11184766
[No Abstract] [Full Text] [Related]
[Next] [New Search]
